HomeCERS • NASDAQ
Cerus Corp
add
$1.29
5.15%
After Hours:(0.00%)0.00
$1.29
Closed: May 9, 4:02:08 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 43.24M | 12.70% |
Operating expense | 31.28M | 6.93% |
Net income | -7.72M | 20.34% |
Net profit margin | -17.85 | 29.31% |
Earnings per share | -0.04 | 20.00% |
EBITDA | -5.55M | 24.52% |
Effective tax rate | -0.97% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 80.92M | 12.11% |
Total assets | 206.78M | 9.33% |
Total liabilities | 150.53M | 8.32% |
Total equity | 56.24M | — |
Shares outstanding | 191.16M | — |
Price to book | 4.69 | — |
Return on assets | -7.18% | — |
Return on capital | -9.42% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -7.72M | 20.34% |
Cash from operations | -844.00K | -143.08% |
Cash from investing | -1.19M | -182.23% |
Cash from financing | 1.07M | -80.74% |
Net change in cash | -776.00K | -108.74% |
Free cash flow | -2.15M | -246.13% |
Previous close
$1.36
Day range
$1.28 - $1.36
Year range
$1.12 - $2.54
Market cap
246.60M USD
Avg Volume
1.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
Founded
Sep 1991
Headquarters
Website
Employees
622
